Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.

A massive degeneration of dopamine-containing neurons in the substantia nigra (SN) in the midbrain is characteristic of Parkinson's disease. Inflammation in the brain has long been speculated to play a role in the pathogenesis of this neurological disorder. Recently, we reported that treatment of primary rat mesencephalic mixed neuron-glia cultures with lipopolysaccharide (LPS) led to the activation of microglia, resident immune cells of the brain, and subsequent death of dopaminergic neurons. The LPS-induced degeneration of dopaminergic neurons was significantly attenuated by the opiate receptor antagonist (-)-naloxone and its inactive isomer (+)-naloxone, with equal potency, through an inhibition of microglial activation and their production of neurotoxic factors. In this study, injection of LPS into the rat SN led to the activation of microglia and degeneration of dopaminergic neurons: microglial activation was observed as early as 6 h and loss of dopaminergic neurons was detected 3 days after the LPS injection. Furthermore, the LPS-induced loss of dopaminergic neurons in the SN was time- and LPS concentration-dependent. Systemic infusion of either (-)-naloxone or (+)-naloxone inhibited the LPS-induced activation of microglia and significantly reduced the LPS-induced loss of dopaminergic neurons in the SN. These in vivo results combined with our cell culture observations confirmed that naloxone protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation and suggest that naloxone would have therapeutic efficacy in the treatment of inflammation-related neurological disorders. In addition, the inflammation-mediated degeneration of dopaminergic neurons in the rat SN resulting from the targeted injection of LPS may serve as a useful model to gain further insights into the pathogenesis of Parkinson's disease.

[1]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[2]  Bin Liu,et al.  Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. , 2000, The Journal of pharmacology and experimental therapeutics.

[3]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[4]  A. Członkowska,et al.  The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse , 1999, Experimental Neurology.

[5]  A. Boyles,et al.  National Institute of Environmental Health Sciences , 2008 .

[6]  P. Damier,et al.  Glial cells and inflammation in parkinson's disease: A role in neurodegeneration? , 1998, Annals of neurology.

[7]  M. Matyszak.  Inflammation in the CNS: balance between immunological privilege and immune responses , 1998, Progress in Neurobiology.

[8]  Y. Hannun,et al.  Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death* , 1998, The Journal of Biological Chemistry.

[9]  J. Cano,et al.  Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System , 1998, Journal of neurochemistry.

[10]  Y Ben-Shlomo,et al.  The epidemiology of Parkinson's disease. , 1997, Bailliere's clinical neurology.

[11]  C. Olanow,et al.  Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.

[12]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[13]  G. Bing,et al.  Induction of NF‐kB‐like transcription factors in brain areas susceptible to kainate toxicity , 1996, Glia.

[14]  G. Levi,et al.  Induction of Prostanoid Biosynthesis by Bacterial Lipopolysaccharide and Isoproterenol in Rat Microglial Cultures , 1995, Journal of neurochemistry.

[15]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[16]  G. Barker,et al.  Magnetic resonance spectroscopic study of parkinsonism related to boxing. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[17]  C. Raine,et al.  Multiple sclerosis: immune system molecule expression in the central nervous system. , 1994, Journal of neuropathology and experimental neurology.

[18]  D W Dickson,et al.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. , 1993, Journal of immunology.

[19]  D. Dickson,et al.  Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.

[20]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[21]  Y. T. Chen,et al.  Naloxone Reversal of Ischemic Arrhythmia Is Stereospecific and Suggests Role of Endogenous Opioid Peptides in Ischemic Heart Disease , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  S. Gruber,et al.  The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. , 1991 .

[23]  V. Perry,et al.  Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain , 1990, Neuroscience.

[24]  H. Tilson,et al.  Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. , 1990, Brain research. Molecular brain research.

[25]  J. Friedman.  Progressive parkinsonism in boxers. , 1989, Southern medical journal.

[26]  S. Styren,et al.  Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.

[27]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[28]  M. Rizzo,et al.  Blindsight: A case study and implications by L. Weiskrantz, Oxford University Press, 1986. £ 19.50 (viii + 187 pages) ISBN 9 18 852129 4 , 1987, Trends in Neurosciences.

[29]  D. Choi,et al.  High concentrations of naloxone attenuate N-methyl-D-aspartate receptor-mediated neurotoxicity. , 1987, European journal of pharmacology.

[30]  M. Fisher,et al.  A Double Blind Trial of Naloxone in the Treatment of Acute Stroke , 1984, Stroke.

[31]  O. Sugar.  Naloxone in the treatment of stroke. , 1982, Surgical neurology.

[32]  A. Brossi,et al.  Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. , 1978, Journal of medicinal chemistry.

[33]  J. Glass,et al.  Human immunodeficiency virus and the brain. , 1996, Annual review of neuroscience.

[34]  A. Casadevall,et al.  Reactive nitrogen intermediates in human neuropathology: an overview. , 1994, Developmental neuroscience.

[35]  A. Faden,et al.  Pharmacological strategies in CNS trauma. , 1992, Trends in pharmacological sciences.

[36]  M. Stern,et al.  Head trauma as a risk factor for Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[37]  K. Jellinger.  Trauma as an etiologic agent in Parkinson disease. , 1989, Movement disorders : official journal of the Movement Disorder Society.

[38]  M. Graeber,et al.  Functional plasticity of microglia: A review , 1988, Glia.

[39]  W. Weiner,et al.  Trauma as an etiology of parkinsonism: A historical review of the concept , 1988, Movement disorders : official journal of the Movement Disorder Society.

[40]  J. Langston,et al.  MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. , 1984, Acta neurologica Scandinavica. Supplementum.

[41]  R. Duvoisin,et al.  Speculations on the etiology of Parkinson's disease. , 1984, Advances in neurology.

[42]  Y. Hosobuchi,et al.  Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. , 1982, Science.